Personas Provides Update on Keek Marketing Launch
Toronto, Ontario–(Newsfile Corp. – September 14, 2023) – Personas Social Incorporated (TSXV: PRSN) (the “Company“)…
News
OutSystems ONE Conference Celebrates Developer Community Growth and More Than 100K New Community Members
Conference gathers 1,600 global developers to advance high-performance low-code education, innovation, and career growth LISBON,…
KBRA Assigns Preliminary Ratings to OBX 2023-NQM7 Trust (OBX 2023-NQM7)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to six classes of mortgage-backed notes from OBX 2023-NQM7…
KBRA Assigns Preliminary Ratings to GCAT 2023-NQM3 Trust
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to six classes of mortgage pass-through notes from GCAT…
Atmosic and Nichicon Announce Energy Harvesting Solution to Reduce Battery Waste in the IoT
New solution will help brands design more sustainable wearable and IoT Bluetooth applications in small…
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to…
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to…
Scilex Holding Company Announces the Completion of its SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, Phase 2 trial which achieved its objectives to Evaluate the Safety and Efficacy of SP-103 in Subjects with Moderate to Severe Acute Lower Back Pain (LBP)
Scilex Holding Company announced completion of its SP-103 Phase 2 study to evaluate the safety…
Scilex Holding Company Announces the Completion of its SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, Phase 2 trial which achieved its objectives to Evaluate the Safety and Efficacy of SP-103 in Subjects with Moderate to Severe Acute Lower Back Pain (LBP)
Scilex Holding Company announced completion of its SP-103 Phase 2 study to evaluate the safety…
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
HAMILTON, BERMUDA , Sept. 14, 2023 (GLOBE NEWSWIRE) — Fresh data from randomized controlled NASAR…
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
HAMILTON, BERMUDA , Sept. 14, 2023 (GLOBE NEWSWIRE) — Fresh data from randomized controlled NASAR…
Rencofilstat Produces Positive Outcomes in Translational Study on Idiopathic Pulmonary Fibrosis
– Proteomics analysis showed that rencofilstat improved aberrant protein profiles in IPF tissues – –…
Rencofilstat Produces Positive Outcomes in Translational Study on Idiopathic Pulmonary Fibrosis
– Proteomics analysis showed that rencofilstat improved aberrant protein profiles in IPF tissues – –…
ngrok Launches Global Server Load Balancing
ngrok’s Out-of-the-Box GSLB Solution Improves Application Performance and Resiliency Without Burdening ITOps SAN FRANCISCO ,…
ibex and Genesys Partner to Deliver Omnichannel AI-enabled Customer Experience and Contact Center Solutions
Strategic Partnership will Enhance Service Delivery, Speed Digital Transformation and Provide Greater Efficiency ibex and…
KORE Power, NIDEC Announce Multi-Year Offtake Agreement, Framework for Future Collaboration
2024 Delivery of at Least 450 MWh of Lithium-Ion Cells, Modules and Racks Growing to…
Intermap’s InsitePro Clients Post Excellent Underwriting Results After Tropical Storm Hilary
InsitePro generates strong recurring revenue growth through the first half of 2023 Annual net retention…
Kontent.ai Announces New Chief Executive Officer, Mark Ruddock
New leadership brings global expertise to the fast-growing CMS organization New York, New York and…
Defense Technologies International Corp. (DTII) Announces a Free Government Benefit Package for Schools
Del Mar, California–(Newsfile Corp. – September 14, 2023) – Defense Technologies International Corp. (OTC Pink:…
Hillcrest UK Tour for Exclusive Financing Forum and Co-Development Sessions
Hillcrest selected to present at exclusive family office event in London Thursday September 21st, 2023…